Ascendis Pharma A ASND
NASDAQ ASND
$227.31 -0.52 (-0.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Invested Capital (2021 - 2026)

Updated

Ascendis Pharma A's Invested Capital was $2.12 billion in the quarter ended Jun 30, 2026, up 150.3% from $845.87 million a year earlier and up 12.1% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Invested Capital (2021 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Invested Capital at Ascendis Pharma A came in at $1.03 billion, up 9.2% from the prior year.

  • Invested Capital shows a four-year compound annual growth rate of -2.2% (years ended Dec 2021 to Dec 2025).
  • In earlier years, Invested Capital was $939.74 million in the year ended Dec 31, 2024 (+38.4%), $678.98 million in the year ended Dec 31, 2023 (-1.0%), $686.02 million in the year ended Dec 31, 2022 (-38.9%) and $1.12 billion in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Invested Capital in data going back to the quarter ended Dec 31, 2021.
  • Compared with a year earlier, Invested Capital has increased for eight straight quarters, with growth averaging 61.8% over the last eight quarters.
  • The best year-over-year quarter for Invested Capital over five years was the quarter ended Jun 30, 2026 (growth of 150.3%); the worst was the quarter ended Jun 30, 2023 (a decline of 49.8%).
  • Per Business Quant data, ASND's Invested Capital in the three quarters before the quarter ended Jun 30, 2026 was $1.89 billion (quarter ended Mar 31, 2026), $1.06 billion (quarter ended Dec 31, 2025) and $955.46 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Ascendis Pharma A 14.12 Bn 10.37 Bn 362.22 Mn 2.12 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.12 Bn
Mar 31, 2026 1.89 Bn
Dec 31, 2025 1.06 Bn
Sep 30, 2025 955.46 Mn
Jun 30, 2025 845.87 Mn
Mar 31, 2025 832.72 Mn
Dec 31, 2024 927.81 Mn
Sep 30, 2024 913.74 Mn
Jun 30, 2024 526.78 Mn
Mar 31, 2024 666.73 Mn
Dec 31, 2023 675.36 Mn
Sep 30, 2023 518.22 Mn
Jun 30, 2023 592.61 Mn
Mar 31, 2023 694.66 Mn
Dec 31, 2022 664.08 Mn
Sep 30, 2022 992.84 Mn
Jun 30, 2022 1.18 Bn
Mar 31, 2022 1.28 Bn
Dec 31, 2021 1.12 Bn
API Access

Ascendis Pharma A Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ASND&period=max&api_key=YOUR_API_KEY